Suchergebnisse - "Brethon, Benoît"

PubPharm (9)

1

Impact of COVID-19 on cancer care : A survey from the French Society of Pediatric Oncology (SFCE)

enthalten in: Pediatric blood & cancer | 2021

von Rouger-Gaudichon, J. | Gariazzo, L. | Thébault, E. | +27

2

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia : results of the RIALTO trial, an expanded access study

enthalten in: Blood cancer journal | 2020

von Locatelli, F. | Zugmaier, G. | Mergen, N. | +8

ErratumIn: Blood Cancer J. 2021 Feb 1;11(2):28. - PMID 33563903

3

Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia

enthalten in: British journal of haematology | 2020

von Calvo, C. | Cabannes-Hamy, A. | Adjaoud, D. | +8

4

COVID-19 in pediatric oncology from French pediatric oncology and hematology centers : High risk of severe forms?

enthalten in: Pediatric blood & cancer | 2020

von André, N. | Rouger-Gaudichon, J. | Brethon, B. | +4

CommentIn: Pediatr Blood Cancer. 2020 Sep;67(9):e28524. - PMID 32618416

5

Tolerance to arsenic trioxide combined with all-trans-retinoic acid in children with acute promyelocytic leukaemia in France

enthalten in: British journal of haematology | 2020

von Garcia Spezza, E. | Brethon, B. | Petit, A. | +7

6

Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation

enthalten in: Haematologica | 2019

von Mouttet, B. | Vinti, L. | Ancliff, P. | +18

7

A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia

enthalten in: British journal of haematology | 2019

von Zwaan, C. | Söderhäll, S. | Brethon, B. | +9

8

Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia

enthalten in: British journal of haematology | 2016

von Derouet, A. | Petit, A. | Baruchel, A. | +6

9

Molecular response in two children with relapsed acute myeloid leukemia treated with a combination of gemtuzumab ozogamicin and cytarabine

enthalten in: Haematologica | 2006

von Brethon, B. | Auvrignon, A. | Cayuela, J. | +3

1
[1]